Pharmaceutical Research Strategies
This study analyses 1400 research projects of the top 20 R&D-spending pharmaceuticals to identify the determinants of successful research projects. We provide clear evidence that externally sourced projects and projects involving biotechnologies perform better than internal projects and chemical projects, respectively. Controlling for these effects, we find that big pharma should either build a critical mass of disease area knowledge or diversify projects over different DA’s in order to obtain higher success probabilities. Projects in which a firm has built a critical mass of disease knowl... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | doc-type:workingPaper |
Erscheinungsdatum: | 2008 |
Verlag/Hrsg.: |
Amsterdam and Rotterdam: Tinbergen Institute
|
Schlagwörter: | ddc:330 / L65 / L25 / L21 / D21 / D83 / research strategies / pharmaceutical industry / innovation / external collaborations / make-or-buy / Pharmazeutische Forschung / Innovationsmanagement / Betriebsgröße / Pharmazeutische Industrie / Niederlande |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26860749 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://hdl.handle.net/10419/86979 |